STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Adaptive Biotechnologies Corp

Filed

March 13, 2024

Period of Report

March 12, 2024

Accession Number

0001062993-24-006350